DSpace UNL

RUN >
Nova School of Business and Economics (NSBE) >
NSBE: Economia e Gestão >
NSBE: Economia e Gestão >
NSBE: EG - Working Papers >

Please use this identifier to cite or link to this item: http://hdl.handle.net/10362/2551

Title: The simple economics of risk-sharing agreements between the NHS and the pharmaceutical industry
Authors: Barros, Pedro
Keywords: risk sharing agreements, pharmaceutical prices
Issue Date: 27-Jan-2010
Abstract: The Janssen-Cilag proposal for a risk-sharing agreement regarding bortezomib received a welcome signal from NICE. The Office of Fair Trading report included risk-sharing agreements as an available tool for the National Health Service. Nonetheless, recent discussions have somewhat neglected the economic fundamentals underlying risk-sharing agreements. We argue here that risk-sharing agreements, although attractive due to the principle of paying by results, also entail risks. Too many patients may be put under treatment even with a low success probability. Prices are likely to be adjusted upward, in anticipation of future risk-sharing agreements between the pharmaceutical company and the third-party payer. An available instrument is a verification cost per patient treated, which allows obtaining the first-best allocation of patients to the new treatment, under the risk sharing agreement. Overall, the welfare effects of risk-sharing agreements are ambiguous, and care must be taken with their use.
URI: http://hdl.handle.net/10362/2551
Appears in Collections:NSBE: EG - Working Papers

Files in This Item:

File Description SizeFormat
barros-sharing.pdf155.63 kBAdobe PDFView/Open
Statistics
View Statistics
FacebookTwitterDeliciousLinkedInDiggGoogle BookmarksMySpaceOrkut
Formato BibTex mendeley Endnote Logotipo do DeGóis 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Universidade Nova de Lisboa  - Statistics  - Feedback
Estamos no RCAAP Governo Português separator Ministério da Educação e Ciência   Fundação para a Ciência e a Tecnologia

Financiado por:

POS_C UE